KLRA is trading 4% down today at $20.51 as the company is expected to report its Q1 2026 earnings today, June 25, 2026. - As a recently listed clinical-stage biotech, the market may be reacting to anticipation or early details from the earnings report, following a multi-day rally from its $16 IPO price in April 2026. - The stock's current price movement occurs amid a mixed broader market tone.